Reviews and Position Papers

R1

Marshall BJ.  Campylobacter pyloridis and Gastritis. J Infect Dis 1986; 52: 650-657.

R1.pdf

R2

Goodwin CS, Armstrong JA, Marshall BJ.  Campylobacter pyloridis, gastritis, and peptic ulceration.  J Clin Pathol 1986; 39: 353-365.

R3

Marshall BJ. Gastric mucosal biopsy: an essential investigation in patients with dyspepsia. Am J Gastroenterol 1988; 83:479-481.

R4

Guerrant RL, Marshall BJ. Human Campylobacter infections. Infections in Medicine 1989; 6:9-14.

R5

Hoffman S, Dye KR, Marshall BJ.  Gastric Urease, Campylobacter pylori and the interpretation of the CLOtest.  Gastroenterology Nursing, 1989;2(4):217-20.

R6

Marshall BJ. Experimental models in vivo for Campylobacter pylori.  Gastroenterol Clin Biol 1989:13, 50B-52B.

R7

Marshall BJ. Campylobacter pylori diagnosis and therapy.  Med J Aust, October 16, 1989;151(8):426-27 [editorial].

R8

Marshall BJ. Campylobacter pylori: its link to gastritis and peptic ulcer disease. Reviews of Infectious Diseases 1990;12 (suppl 1):S87-S93.

R9

Hoffman SR, Marshall BJ. Peptic ulcer disease. American Journal of Continuing Education in Nursing 1991 (review):1-6.

R10

Marshall BJ. The use of bismuth in gastroenterology. Am J Gastro, 1991;86(1):16-25.

R11

Marshall BJ.  Virulence and pathogenicity of Helicobacter pylori. J Gastroenterology and Hepatology, 1991;6:121-124.

R12

Marshall BJ. Helicobacter pylori: A primer for 1994. The Gastroenterologist, 1(4):241-7, 1993.

R13

DeCross AJ, Marshall BJ. The role of Helicobacter pylori in acid-peptic disease. Am J of the Med Sci, 306(6):381-92, 1993.

R14

Marshall BJ. Helicobacter pylori. [Review].  American Journal of Gastroenterology  89(8 Suppl):S116-28, 1994 Aug.

R15

Marshall BJ. Helicobacter pylori the Etiologic Agent for Peptic Ulcer. JAMA 274(13):1064-1066, 1995.

R16

Graham DY, Rakel RE, Fendrick MA, Go MF, Marshall BJ, Peura DA, Scherger JE. “Paradigm”.  Managing peptic ulcer disease in the era of Helicobacter pylori.  An H. pylori book USA doctors and patients. With Medical Communications New York.

R17

Graham DY, Marshall BJ, et al. Managing peptic ulcer disease: The scope of the problem and the nature of Helicobacter pylori (Clinical and laboatory diagnosis).With Health Communications Inc. New York.  Submitted to JAMA 1997 [citation requested].

R18

Graham DY, Marshall BJ, et al. Managing peptic ulcer disease: Therapy. With Health Communications Inc. New York.  Submitted to JAMA 1997 [citation requested].

R19

Pattison CP, Combs MJ, Marshall BJ.  Helicobacter pylori and peptic ulcer disease: Evolution to revolution to resolution.  American Journal of Roentgenology 1997;168(6):1415-1420.

R20

Marshall B. Commentary: Helicobacter  as the ‘environmental factor’ in Susser and Stein’s cohort theory in peptic ulcer disease. International Journal of Epidemiology 2002; 31:21-22.

R21

Talley NJ, Vakil N, Delaney B, Marshall B, Bytzer P, Engstrand L., et al. Management issues in dyspepsia: current consensus and controversies. Scand J Gastroenterol 2004;39(10):913-918.

R22

Australian Government Legislation Review: Prohibition of Human Cloning Act 2002 and the Research involving Human Embryos Act 2002, Reports, Canberra, December 2005.

R23

Marshall B. Commentary: A unifying mathematical hypothesis for the epidemiology of Helicobacter-associated diseases – plurality should not be assumed without necessity. International Journal of Epidemiology 2006;35:1097-8.

R24

Marshall B. Editorial: Sequential therapy for Helicobacter pylori: A worthwhile effort for your patients. Annals of Internal Medicine 2008;148:962-963.